Research output

Research output per year 2001 2007 2010 2011 2012 2014 2018 2019 2020 2021 2022

• 9689 Citations
• 53 Scopus h-Index
• 169 Article
• 63 Review article
• 11 Chapter
• 11 Letter
• 18 More
  • 8 Editorial
  • 7 Short survey
  • 3 Comment/debate

Research output per year

Research output per year

Search results

• 2022

  Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy

  Klomjit, N., El Ters, M., Adam, B. A., Sampathkumar, P., Razonable, R. R., Taler, S. J., Taner, T. & Alexander, M. P., Jan 2022, In: American Journal of Transplantation. 22, 1, p. 289-293 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Capillaries 100%
  • Allografts 90%
  • Staining and Labeling 66%
  • Kidney 55%
  • Antibodies 45%
• 2021

  Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a “Safe Corridor” after kidney transplantation?

  El Helou, G., Lahr, B. & Razonable, R., Apr 2021, In: Transplant Infectious Disease. 23, 2, e13489.

  Research output: Contribution to journal › Article › peer-review

  • Lymphocyte Count 100%
  • Cytomegalovirus 91%
  • Kidney Transplantation 87%
  • Allografts 80%
  • Cytomegalovirus Infections 29%

• A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model

  Razonable, R. R., Aloia, N. C. E., Anderson, R. J., Anil, G., Arndt, L. L., Arndt, R. F., Ausman, S. E., Bell, S. J., Bierle, D. M., Billings, M. L., Bishop, R. K., Cramer, C. H., Culbertson, T. L., Dababneh, A. S., Derr, A. N., Epps, K., Flaker, S. M., Ganesh, R., Gilmer, M. A., Urena, E. G. & 50 others, Gulden, C. R., Haack, T. L., Hanson, S. N., Herzog, J. R., Heyliger, A., Hokanson, L. D., Hopkins, L. H., Horecki, R. J., Krishna, B. H., Huskins, W. C., Jackson, T. A., Johnson, R. R., Jorgenson, B., Kudrna, C., Kennedy, B. D., Klingsporn, M. K., Kottke, B., Larsen, J. J., Lessard, S. R., Lutwick, L. I., Malone, E. J., Matoush, J. A., Micallef, I. N., Moehnke, D. E., Mohamed, M., Ness, C. N., Olson, S. M., Orenstein, R., Palraj, R., Patel, J., Paulson, D. J., Phelan, D., Peinovich, M. T., Ramsey, W. L., Rau-Kane, T. J., Reid, K. I., Reinschmidt, K. J., Seville, M. T., Skold, E. C., Smith, J. M., Speicher, L. L., Spielman, L. A., Springer, D. J., Sweeten, P. W., Tempelis, J. M., Tulledge-Scheitel, S., Vergidis, P., Whipple, D. C., Wilker, C. G. & Destro Borgen, M. J., May 2021, In: Mayo Clinic proceedings. 96, 5, p. 1250-1261 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Coronavirus 100%
  • Outpatients 59%
  • Monoclonal Antibodies 58%
  • Occupational Groups 42%
  • Medical Ethics 27%

• A mobile unit overcomes the challenges to monoclonal antibody infusion for COVID-19 in skilled care facilities

  Tulledge-Scheitel, S., Bell, S. J., Larsen, J. J., Bierle, D. M., Takahashi, P., Moehnke, D. E., Destro Borgen, M. J., Springer, D. J., Reinschmidt, K. J., Baumbach, L. J., Matoush, J. A., Heyliger, A., Hanson, S. N., Razonable, R. R. & Ganesh, R., Apr 2021, In: Journal of the American Geriatrics Society. 69, 4, p. 868-873 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Skilled Nursing Facilities 100%
  • Coronavirus 91%
  • Monoclonal Antibodies 52%
  • Hospitalization 21%
  • Emergency Treatment 17%
  1 Scopus citations

• Association of hhv-6 with outcomes in cmvseronegative liver transplant recipients with cmv-seropositive donors receiving preemptive antiviral therapy

  Singh, N., Winston, D. J., Razonable, R. R., Marshall Lyon, G., Huang, M. L., Jerome, K. R., Silveira, F. P., Wagener, M. M. & Limaye, A. P., Nov 1 2021, In: Transplantation. 105, 11, p. 2427-2434 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Human Herpesvirus 6 100%
  • Viremia 83%
  • Transplant Recipients 68%
  • Liver Transplantation 67%
  • Antiviral Agents 63%

• A tale of two unusual anaerobic bacterial infections in an immunocompetent man: A case report and literature review

  Chesdachai, S., Eberly, A. R. & Razonable, R. R., Oct 2021, In: Anaerobe. 71, 102416.

  Research output: Contribution to journal › Article › peer-review

  • Desulfovibrio 100%
  • Epidural Abscess 84%
  • Bacteremia 60%
  • Bacterial Infections 55%

• Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge

  Bierle, D. M., Ganesh, R. & Razonable, R. R., Dec 2021, In: Journal of Clinical Virology. 145, 105026.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Hospitalization 40%
  • Midwestern United States 20%
  • Monoclonal Antibodies 19%
  • Therapeutics 11%

• Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19

  Razonable, R. R., Pawlowski, C., O'Horo, J. C., Arndt, L. L., Arndt, R., Bierle, D. M., Borgen, M. D., Hanson, S. N., Hedin, M. C., Lenehan, P., Puranik, A., Seville, M. T. A., Speicher, L. L., Tulledge-Scheitel, S., Venkatakrishnan, A. J., Wilker, C. G., Badley, A. D. & Ganesh, R., Oct 2021, In: EClinicalMedicine. 40, 101102.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Hospitalization 58%
  • Confidence Intervals 35%
  • Antibodies 22%
  • Chronic Renal Insufficiency 18%

• Chronic graft-versus-host disease in pancreas after kidney transplant recipients – An unrecognized entity

  Singh, P., Razonable, R. R., Lorenz, E. C., DiCaudo, D. J., Sukov, W. R., Bridges, A. G., Alkhateeb, H. B., Hogan, W. J., Klomjit, N., Thirunavukkarasu, S., Amer, H., Kudva, Y. C., Khamash, H., Stegall, M. & Kukla, A., Feb 2021, In: American Journal of Transplantation. 21, 2, p. 883-888 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Graft vs Host Disease 100%
  • Transplant Recipients 88%
  • Pancreas 81%
  • Kidney 50%
  • Transplants 47%

• Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients with Seropositive Donors

  Singh, N., Winston, D. J., Razonable, R. R., Lyon, G. M., Silveira, F. P., Wagener, M. M. & Limaye, A. P., Nov 1 2021, In: Clinical Infectious Diseases. 73, 9, p. E2739-E2745

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus 100%
  • Transplant Recipients 93%
  • Liver Transplantation 91%
  • Tissue Donors 78%
  • Randomized Controlled Trials 67%

• Fungal Infection in Lung Transplantation

  Kennedy, C. C., Pennington, K. M., Beam, E. & Razonable, R. R., Jun 1 2021, In: Seminars in Respiratory and Critical Care Medicine. 42, 3, p. 471-482 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Invasive Fungal Infections 100%
  • Lung Transplantation 89%
  • Mycoses 78%
  • Culture Techniques 50%
  • Antifungal Agents 45%

• Individualized management of cytomegalovirus in solid organ transplant recipients

  Saeed, H., Thoendel, M. & Razonable, R. R., 2021, In: Expert Review of Precision Medicine and Drug Development. 6, 5, p. 333-344 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphopenia 100%
  • Refractory 52%
  • Cytomegalovirus 50%
  • Transplant Recipients 47%
  • Dose 39%

• Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19

  Bierle, D. M., Ganesh, R., Wilker, C. G., Hanson, S. N., Moehnke, D. E., Jackson, T. A., Ramar, P., Rosedahl, J. K., Philpot, L. M. & Razonable, R. R., 2021, In: Journal of Primary Care and Community Health. 12

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • cultural factors 77%
  • social factors 66%
  • Monoclonal Antibodies 58%
  • comorbidity 32%

• Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19

  Ganesh, R., Pawlowski, C. F., O'Horo, J. C., Arndt, L. L., Arndt, R. F., Bell, S. J., Bierle, D. M., Borgen, M. D., Hanson, S. N., Heyliger, A., Larsen, J. J., Lenehan, P. J., Orenstein, R., Puranik, A., Speicher, L. L., Tulledge-Scheitel, S. M., Venkatakrishnan, A. J., Wilker, C. G., Badley, A. D. & Razonable, R. R., Oct 2021, In: Journal of Clinical Investigation. 131, 19, e151697.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Hospitalization 58%
  • Odds Ratio 51%
  • Intensive Care Units 16%
  • Dizziness 10%

• Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient

  Yohanathan, L., Campioli, C. C., Mousa, O. Y., Watt, K., Friedman, D. Z. P., Shah, V., Ramkissoon, R., Hines, A. S., Kamath, P. S., Razonable, R. R., Badley, A. D., DeMartino, E. S., Joyner, M. J., Graham, R., Vergidis, P., Simonetto, D. A., Sanchez, W., Taner, T., Heimbach, J. K., Beam, E. & 1 others, Leise, M. D., Aug 2021, In: American Journal of Transplantation. 21, 8, p. 2890-2894 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Acute Liver Failure 90%
  • Liver Transplantation 70%
  • Polymerase Chain Reaction 45%

• Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients

  Yetmar, Z. A., Beam, E., O'Horo, J. C., Ganesh, R., Bierle, D. M., Brumble, L., Seville, M. T. & Razonable, R. R., Jun 1 2021, In: Open Forum Infectious Diseases. 8, 6, ofab255.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Transplant Recipients 73%
  • Monoclonal Antibodies 58%
  • Transplants 49%
  • Pancreas 19%

• Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

  O'Horo, J. C., Cerhan, J. R., Cahn, E. J., Bauer, P. R., Temesgen, Z., Ebbert, J., Abril, A., Abu Saleh, O. M., Assi, M., Berbari, E. F., Bierle, D. M., Bosch, W., Burger, C. D., Cano Cevallos, E. J., Clements, C. M., Carmona Porquera, E. M., Castillo Almeida, N. E., Challener, D. W., Chesdachai, S., Comba, I. Y. & 58 others, Corsini Campioli, C. G., Crane, S. J., Dababneh, A. S., Enzler, M. J., Fadel, H. J., Ganesh, R., De Moraes, A. G., Go, J. R., Gordon, J. E., Gurram, P. R., Guru, P. K., Halverson, E. L., Harrison, M. F., Heaton, H. A., Hurt, R., Kasten, M. J., Lee, A. S., Levy, E. R., Libertin, C. R., Mallea, J. M., Marshall, W. F., Matcha, G., Meehan, A. M., Franco, P. M., Morice, W. G., O'Brien, J. J., Oeckler, R., Ommen, S., Oravec, C. P., Orenstein, R., Ough, N. J., Palraj, R., Patel, B. M., Pureza, V. S., Pickering, B., Phelan, D. M., Razonable, R. R., Rizza, S., Sampathkumar, P., Sanghavi, D. K., Sen, A., Siegel, J. L., Singbartl, K., Shah, A. S., Shweta, F. N. U., Speicher, L. L., Suh, G., Tabaja, H., Tande, A., Ting, H. H., Tontz, R. C., Vaillant, J. J., Vergidis, P., Warsame, M. Y., Yetmar, Z. A., Zomok, C. C. D., Williams, A. W. & Badley, A. D., Mar 2021, In: Mayo Clinic proceedings. 96, 3, p. 601-618 18 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Intensive Care Units 21%
  • Mortality 13%
  • Hospitalization 13%
  • Pandemics 9%
  3 Scopus citations

• Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity

  Kirisri, S., Vongsakulyanon, A., Kantachuvesiri, S., Razonable, R. R. & Bruminhent, J., Jun 1 2021, In: Open Forum Infectious Diseases. 8, 6, ofab199.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytomegalovirus Infections 100%
  • Humoral Immunity 93%
  • Cytomegalovirus 90%
  • Transplant Recipients 84%
  • Kidney 48%

• Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab among High-Risk Patients with Mild to Moderate Coronavirus Disease 2019

  Ganesh, R., Philpot, L. M., Bierle, D. M., Anderson, R. J., Arndt, L. L., Arndt, R. F., Culbertson, T. L., Destro Borgen, M. J., Hanson, S. N., Kennedy, B. D., Kottke, B. B., Larsen, J. J., Ramar, P., Rosedahl, J. K., Seville, M. T., Speicher, L. L., Tulledge-Scheitel, S. M., Wilker, C. G. & Razonable, R. R., Oct 15 2021, In: Journal of Infectious Diseases. 224, 8, p. 1278-1286 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Hospitalization 58%
  • Comorbidity 35%
  • Monoclonal Antibodies 16%
  • Chronic Renal Insufficiency 10%

• Risk Factors for Cytomegalovirus Viremia following Liver Transplantation with a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy

  Singh, N., Winston, D. J., Razonable, R. R., Lyon, G. M., Silveira, F. P., Wagener, M. M. & Limaye, A. P., Mar 15 2021, In: Journal of Infectious Diseases. 223, 6, p. 1073-1077 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Viremia 100%
  • Cytomegalovirus 88%
  • Liver Transplantation 80%
  • Antiviral Agents 76%
  • Tissue Donors 69%

• The Impact of Antifungal Prophylaxis in Lung Transplant Recipients

  Pennington, K. M., Dykhoff, H. J., Yao, X., Sangaralingham, L. R., Shah, N. D., Peters, S. G., Barreto, J. N., Razonable, R. R. & Kennedy, C. C., Mar 2021, In: Annals of the American Thoracic Society. 18, 3, p. 468-476 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Invasive Fungal Infections 100%
  • Transplant Recipients 71%
  • Lung 41%
  • Mortality 32%
  • Transplants 16%
  1 Scopus citations

• The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy

  Kates, O. S., Stohs, E. J., Pergam, S. A., Rakita, R. M., Michaels, M. G., Wolfe, C. R., Danziger-Isakov, L., Ison, M. G., Blumberg, E. A., Razonable, R. R., Gordon, E. J. & Diekema, D. S., Aug 2021, In: American Journal of Transplantation. 21, 8, p. 2637-2645 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Vaccination Refusal 100%
  • Ethical Review 88%
  • Organ Transplantation 63%
  • Transplantation 44%
  • Vaccines 43%
  1 Scopus citations
• 2020

  Antifungal prophylaxis in lung transplant recipients: A systematic review and meta-analysis

  Pennington, K. M., Baqir, M., Erwin, P. J., Razonable, R. R., Murad, M. H. & Kennedy, C. C., Aug 1 2020, In: Transplant Infectious Disease. 22, 4, e13333.

  Research output: Contribution to journal › Article › peer-review

  • Mycoses 100%
  • Transplant Recipients 91%
  • Meta-Analysis 73%
  • Systematic Reviews 72%
  • Lung 52%
  3 Scopus citations

• Augmented curation of clinical notes from a massive ehr system reveals symptoms of impending covid-19 diagnosis

  Wagner, T., Shweta, F. N. U., Murugadoss, K., Awasthi, S., Venkatakrishnan, A. J., Bade, S., Puranik, A., Kang, M., Pickering, B. W., O’horo, J. C., Bauer, P. R., Razonable, R. R., Vergidis, P., Temesgen, Z., Rizza, S., Mahmood, M., Wilson, W. R., Challener, D., Anand, P., Liebers, M. & 11 others, Doctor, Z., Silvert, E., Solomon, H., Anand, A., Barve, R., Gores, G., Williams, A. W., Morice, W. G., Halamka, J., Badley, A. & Soundararajan, V., Jul 2020, In: eLife. 9, p. 1-12 12 p., e58227.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Chills 100%
  • Electronic Health Records 79%
  • Dysgeusia 79%
  • Olfaction Disorders 74%
  • Fever 58%
  15 Scopus citations

• Clinical diagnostic testing for human cytomegalovirus infections

  Razonable, R. R., Inoue, N., Pinninti, S. G., Boppana, S. B., Lazzarotto, T., Gabrielli, L., Simonazzi, G., Pellett, P. E. & Schmid, D. S., 2020, In: Journal of Infectious Diseases. 221, p. S74-S85

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cytomegalovirus Infections 100%
  • Transplants 22%
  • Sensorineural Hearing Loss 20%
  • Cytomegalovirus 18%
  • Infections 17%
  3 Scopus citations

• Clostridium paraputrificum septic arthritis and osteomyelitis of shoulder: A case report and review of literature

  Vijayvargiya, P., Garrigos, Z. E., Rodino, K. G., Razonable, R. R. & Abu Saleh, O. M., Apr 2020, In: Anaerobe. 62, 102105.

  Research output: Contribution to journal › Article › peer-review

  • Infectious Arthritis 100%
  • Clostridium 99%
  • Synovial Fluid 90%
  • Osteomyelitis 86%
  • Ertapenem 78%
  1 Scopus citations

• Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?

  Cano, E. J., Yetmar, Z. A. & Razonable, R. R., Dec 1 2020, In: Open Forum Infectious Diseases. 7, 12, ofaa527.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cryptococcus gattii 100%
  • Cryptococcus 84%
  • Cryptococcus neoformans 77%
  • Introduced Species 9%
  • Griseofulvin 8%

• Cytomegalovirus in solid organ transplant recipients: Clinical updates, challenges and future directions

  Razonable, R. R., 2020, In: Current pharmaceutical design. 26, 28, p. 3497-3506 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Valganciclovir 100%
  • Ganciclovir 82%
  • Cytomegalovirus 52%
  • Transplant Recipients 48%
  • Direction compound 37%
  2 Scopus citations

• Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients with Seropositive Donors: A Randomized Clinical Trial

  Singh, N., Winston, D. J., Razonable, R. R., Lyon, G. M., Silveira, F. P., Wagener, M. M., Stevens-Ayers, T., Edmison, B., Boeckh, M. & Limaye, A. P., Apr 14 2020, In: JAMA - Journal of the American Medical Association. 323, 14, p. 1378-1387 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus 100%
  • Transplant Recipients 93%
  • Liver Transplantation 91%
  • Antiviral Agents 86%
  • Tissue Donors 78%
  17 Scopus citations

• GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

  Temesgen, Z., Assi, M., Shweta, F. N. U., Vergidis, P., Rizza, S. A., Bauer, P. R., Pickering, B. W., Razonable, R. R., Libertin, C. R., Burger, C. D., Orenstein, R., Vargas, H. E., Palraj, R., Dababneh, A. S., Chappell, G., Chappell, D., Ahmed, O., Sakemura, R., Durrant, C., Kenderian, S. S. & 1 others, Badley, A. D., Nov 2020, In: Mayo Clinic proceedings. 95, 11, p. 2382-2394 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Granulocyte-Macrophage Colony-Stimulating Factor 83%
  • Pneumonia 64%
  • Cohort Studies 54%
  • Investigational New Drug Application 9%
  18 Scopus citations
• 2019

  A Fatal Case of Disseminated Microsporidiosis Due to Anncaliia algerae in a Renal and Pancreas Allograft Recipient

  Anderson, N. W., Muehlenbachs, A., Arif, S., Bruminhent, J., Deziel, P. J., Razonable, R. R., Wilhelm, M. P., Metcalfe, M. G., Qvarnstrom, Y. & Pritt, B. S., Jul 1 2019, In: Open Forum Infectious Diseases. 6, 7, ofz285.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Microsporidiosis 100%
  • Opportunistic Infections 69%
  • Immunocompromised Host 67%
  • Transplant Recipients 58%
  • Allografts 55%
  3 Scopus citations

• Antifungal prophylaxis in lung transplant: A survey of United States' transplant centers

  Pennington, K. M., Yost, K. J., Escalante, P., Razonable, R. R. & Kennedy, C. C., Jul 2019, In: Clinical Transplantation. 33, 7, e13630.

  Research output: Contribution to journal › Article › peer-review

  • Transplants 100%
  • Lung 85%
  • Amphotericin B 44%
  • Physician Executives 27%
  • Triazoles 27%
  5 Scopus citations

• Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic's First Face Transplant

  Razonable, R. R., Amer, H. & Mardini, S., Jan 2019, In: Mayo Clinic proceedings. 94, 1, p. 166-170 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Facial Transplantation 100%
  • Cytomegalovirus 60%
  • Valganciclovir 42%
  • T-Lymphocytes 13%
  • Immunity 9%
  7 Scopus citations

• A survey of infection prevention and control practices among solid organ transplantation centers

  Beam, E. & Razonable, R. R., Jan 2019, In: American journal of infection control. 47, 1, p. 101-104 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Organ Transplantation 100%
  • Infection Control 93%
  • Communicable Diseases 39%
  • Transplantation 35%
  • contagious disease 30%

• Clinical correlation of cytomegalovirus infection with cmv-specific cd8+ t-cell immune competence score and lymphocyte subsets in solid organ transplant recipients

  Meesing, A., Abraham, R. S. & Razonable, R. R., Apr 1 2019, In: Transplantation. 103, 4, p. 832-838 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Lymphocyte Subsets 100%
  • Cytomegalovirus Infections 97%
  • Cytomegalovirus 88%
  • Mental Competency 85%
  • Transplant Recipients 82%
  10 Scopus citations

• Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

  Razonable, R. R. & Humar, A., Sep 1 2019, In: Clinical Transplantation. 33, 9, e13512.

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus 100%
  • Communicable Diseases 85%
  • Transplantation 76%
  • Transplants 62%
  • Cytomegalovirus Infections 27%
  99 Scopus citations

• Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials

  Chemaly, R. F., Chou, S., Einsele, H., Griffiths, P., Avery, R., Razonable, R. R., Mullane, K. M., Kotton, C., Lundgren, J., Komatsu, T. E., Lischka, P., Josephson, F., Douglas, C. M., Umeh, O., Miller, V. & Ljungman, P., Apr 8 2019, In: Clinical Infectious Diseases. 68, 8, p. 1420-1426 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus Infections 100%
  • Cytomegalovirus 90%
  • Transplant Recipients 84%
  • Clinical Trials 59%
  • Antiviral Agents 38%
  37 Scopus citations

• Destination joint spacers, reinfection, and antimicrobial suppression

  Valencia, J. C. B., Abdel, M. P., Virk, A., Osmon, D. R. & Razonable, R. R., Aug 30 2019, In: Clinical Infectious Diseases. 69, 6, p. 1056-1059 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Joint Prosthesis 100%
  • Drainage 57%
  • Joints 47%
  1 Scopus citations

• Differences in Duration and Degree of Cytomegalovirus DNAemia Observed with Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care

  Meesing, A., Germer, J. J., Yao, J. D., Gartner, M. L., Digmann, B. J. & Razonable, R. R., Dec 1 2019, In: Journal of Nutrition. 149, p. 251-255 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus 100%
  • Nucleic Acids 98%
  • Viral Load 16%
  • Retreatment 10%
  • Patient Care 6%
  3 Scopus citations

• Long-term Outcomes of Patients with Human Herpesvirus 6 Encephalitis

  Fida, M., Hamdi, A. M., Bryson, A., Razonable, R. R. & Abu Saleh, O., Jul 1 2019, In: Open Forum Infectious Diseases. 6, 7, ofz269.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Human Herpesvirus 6 encephalitis 100%
  • Human Herpesvirus 6 35%
  • Hematopoietic Stem Cell Transplantation 28%
  • Encephalitis 27%
  • Hematologic Neoplasms 26%
  4 Scopus citations

• Relationship of ganciclovir therapeutic drug monitoring with clinical efficacy and patient safety

  Ritchie, B. M., Barreto, J. N., Barreto, E. F., Crow, S. A., Dierkhising, R. A., Jannetto, P. J., Tosh, P. K. & Razonable, R. R., Mar 2019, In: Antimicrobial Agents and Chemotherapy. 63, 3, e01855-18.

  Research output: Contribution to journal › Article › peer-review

  • Ganciclovir 100%
  • Patient Safety 79%
  • Viral Load 34%
  • Cytomegalovirus 26%
  • Cytomegalovirus Infections 19%
  13 Scopus citations

• Why do lung transplant patients discontinue triazole prophylaxis?

  Pennington, K. M., Razonable, R. R., Peters, S., Scott, J. P., Wylam, M., Daly, R. C. & Kennedy, C. C., Jun 2019, In: Transplant Infectious Disease. 21, 3, e13067.

  Research output: Contribution to journal › Article › peer-review

  • Triazoles 100%
  • Itraconazole 88%
  • Voriconazole 74%
  • posaconazole 62%
  • Transplants 46%
  8 Scopus citations
• 2018

  Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection after Transplantation

  Meesing, A. & Razonable, R. R., Oct 1 2018, In: Open Forum Infectious Diseases. 5, 10, ofy230.

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus Infections 100%
  • Lymphocyte Count 98%
  • Hematopoietic Stem Cells 89%
  • Transplant Recipients 84%
  • Transplantation 69%
  12 Scopus citations

• An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults

  Abad, C. L. R. & Razonable, R. R., Jan 1 2018, (Accepted/In press) In: Clinical Transplantation. e13430.

  Research output: Contribution to journal › Article › peer-review

  • Hematopoietic Stem Cell Transplantation 100%
  • Tuberculosis 77%
  • Mycobacterium tuberculosis 36%
  • Transplantation 28%
  • Fever 28%
  5 Scopus citations

• Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia

  Beam, E., Germer, J. J., Lahr, B., Yao, J. D. C., Limper, A. H., Binnicker, M. J. & Razonable, R. R., Jan 1 2018, In: Clinical Transplantation. 32, 1, e13149.

  Research output: Contribution to journal › Article › peer-review

  • Bronchoalveolar Lavage Fluid 100%
  • Immunocompromised Host 98%
  • Cytomegalovirus 92%
  • Pneumonia 74%
  • DNA 51%
  12 Scopus citations

• Drug-resistant cytomegalovirus: clinical implications of specific mutations

  Razonable, R. R., Aug 1 2018, In: Current opinion in organ transplantation. 23, 4, p. 388-394 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus 100%
  • Mutation 56%
  • Antiviral Agents 43%
  • Pharmaceutical Preparations 41%
  • Ganciclovir 31%
  27 Scopus citations

• Effects of clotrimazole troches on tacrolimus dosing in heart transplant recipients

  Laub, M. R., Crow, S. A., Personett, H. A., Dierkhising, R., Boilson, B. & Razonable, R., Dec 2018, In: Transplant Infectious Disease. 20, 6, e12979.

  Research output: Contribution to journal › Article › peer-review

  • Clotrimazole 100%
  • Tacrolimus 76%
  • Transplant Recipients 65%
  • Heart 46%
  • Oral Candidiasis 11%
  5 Scopus citations

• Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases

  Abad, C. L. R. & Razonable, R. R., Jan 1 2018, (Accepted/In press) In: Clinical Transplantation.

  Research output: Contribution to journal › Article › peer-review

  • Organ Transplantation 100%
  • Mycobacterium tuberculosis 90%
  • Tuberculosis 76%
  • Transplants 19%
  • Infections 14%
  24 Scopus citations
• 2017

  Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials

  Ljungman, P., Boeckh, M., Hirsch, H. H., Josephson, F., Lundgren, J., Nichols, G., Pikis, A., Razonable, R. R., Miller, V. & Griffiths, P. D., Jan 1 2017, In: Clinical Infectious Diseases. 64, 1, p. 87-91 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cytomegalovirus Infections 100%
  • Clinical Trials 59%
  • Transplants 56%
  • Cytomegalovirus 45%
  • Drug Development 42%
  326 Scopus citations

• Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients

  Bruminhent, J., Cawcutt, K. A., Thongprayoon, C., Petterson, T. M., Kremers, W. K. & Razonable, R. R., Jun 1 2017, In: Clinical Transplantation. 31, 6, e12968.

  Research output: Contribution to journal › Article › peer-review

  • Clostridium Infections 100%
  • Transplant Recipients 74%
  • Epidemiology 62%
  • Heart 51%
  • Lung 42%
  8 Scopus citations